In February, the Ontario Divisional Court struck down legislation that banned the sale of private-label generic drugs—drugs made by a company owned by pharmacies—in the Ontario market. ...read more
According to recent data from the Centers for Disease Control and Prevention (CDC), approximately 48 million people get sick, 128,000 are hospitalized and 3,000 die each year from foodborne diseas...read more
“The Center is in the midst of a perfect storm and we don’t know where things will come out,” declared Jeffrey E. Shuren, Director, Center for Devices and Radiological Health at F...read more
Methamphetamine is a highly-addictive stimulant classified as a Schedule II controlled substance under the federal Controlled Substances Act (CSA) and DEA regulations.1 Methamphetamine has limited ...read more
What do a gallon of gasoline, a cup of coffee and an FDA Warning Letter have in common? As of late 2010, they are among the items you might find at a convenience store in a Mississippi town. FDA cl...read more
“How do we deal with the 21 million products that are coming into the country every year?” John Verbeten, Director of the Operations and Policy Branch at FDA’s Office of Regulator...read more
Government, legal, scientific and academic speakers discussed the complex mix of scientific and ethical issues involved in genetically engineered (GE) animals. Moderator Jeannie M. Perron, Of Couns...read more
The Top 20 Food and Drug Law Cases of 2010 fall thematically into a few categories, explained moderator John Reiss, a partner at Saul Ewing LLP. Reiss, editor of the book by the same name, explaine...read more
It lies idyllically amidst the sloshing waves of an imagination made fertile by too many sleepless nights crowded out with billable hours, nervous witnesses, unfinished briefs, client trolling, una...read more
As reflected throughout this issue of Update, the FDLI 2011 Annual Conference brought together participants from many sectors of our community: regulators, the regulated, those who counsel and cons...read more